CVS Health Corp. buy JPMorgan Chase & Co.
Summary
This prediction is currently active. With a performance of 3.01%, the BUY prediction by JPMorgan_Chase___Co_ for CVS Health Corp. is trending in the right direction. Dividends of €0.61 are taken into consideration when calculating the performance. This prediction currently runs until 30.05.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
CVS Health Corp. | -0.831% | -0.831% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CVS Health Corp. diskutieren